Connect your AI

LivaNova LIVN Accrued Contingent Liabilities

Accrued Contingent Liabilities at other companies

MedtronicMDT

——

ResMedRMD

——

SolventumSOLV

——

Other financials

Income statement

Revenue$362.3M+14.3%

Gross profit$243.7M+12.7%

Operating income$41.5M-14.7%

Net income$22.3M+107%

EPS (diluted)$0.40+107%

Balance sheet

Cash & equivalents$539.7M-26.9%

Total debt$340.9M-49.7%

Total equity$1.2B+17.1%

Total assets$2.5B-1.7%

Cash flow

Operating cash flow$15.2M-36.5%

CapEx$14.3M+32.4%

Free cash flow$926.0K-93.0%

Valuation

Market cap$4.32B+62.8%

Profitability

Gross margin67.5%-0.5pp

Operating margin13.4%+0.8pp

Net margin-16.1%-18.0pp

FCF margin11.2%-0.2pp

Returns & leverage

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.4×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:LossContingencyAccrualCarryingValueNoncurrent.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's accrued contingent liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LivaNova's accrued contingent liabilities?: LivaNova (LIVN) reported accrued contingent liabilities of $3M in Q1 2026.
How has LivaNova's accrued contingent liabilities changed year-over-year?: LivaNova's accrued contingent liabilities decreased by 1.3% year-over-year, from $3.04M to $3M.